Caseware UK (AP4) 2022.0.179 2022.0.179 2023-12-312023-12-312023-01-01falseprovision of pharmaceutical products and software77falsetrue 07990372 2023-01-01 2023-12-31 07990372 2022-01-01 2022-12-31 07990372 2023-12-31 07990372 2022-12-31 07990372 c:Director7 2023-01-01 2023-12-31 07990372 d:PlantMachinery 2023-01-01 2023-12-31 07990372 d:PlantMachinery 2023-12-31 07990372 d:PlantMachinery 2022-12-31 07990372 d:PlantMachinery d:OwnedOrFreeholdAssets 2023-01-01 2023-12-31 07990372 d:FurnitureFittings 2023-01-01 2023-12-31 07990372 d:FurnitureFittings 2023-12-31 07990372 d:FurnitureFittings 2022-12-31 07990372 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-01-01 2023-12-31 07990372 d:OfficeEquipment 2023-01-01 2023-12-31 07990372 d:OfficeEquipment 2023-12-31 07990372 d:OfficeEquipment 2022-12-31 07990372 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-01-01 2023-12-31 07990372 d:OwnedOrFreeholdAssets 2023-01-01 2023-12-31 07990372 d:CurrentFinancialInstruments 2023-12-31 07990372 d:CurrentFinancialInstruments 2022-12-31 07990372 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 07990372 d:CurrentFinancialInstruments d:WithinOneYear 2022-12-31 07990372 d:ShareCapital 2023-12-31 07990372 d:ShareCapital 2022-12-31 07990372 d:SharePremium 2023-01-01 2023-12-31 07990372 d:SharePremium 2023-12-31 07990372 d:SharePremium 2022-12-31 07990372 d:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 07990372 d:RetainedEarningsAccumulatedLosses 2023-12-31 07990372 d:RetainedEarningsAccumulatedLosses 2022-12-31 07990372 c:OrdinaryShareClass1 2023-01-01 2023-12-31 07990372 c:OrdinaryShareClass1 2023-12-31 07990372 c:OrdinaryShareClass1 2022-12-31 07990372 c:FRS102 2023-01-01 2023-12-31 07990372 c:Audited 2023-01-01 2023-12-31 07990372 c:FullAccounts 2023-01-01 2023-12-31 07990372 c:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 07990372 d:WithinOneYear 2023-12-31 07990372 d:WithinOneYear 2022-12-31 07990372 d:BetweenOneFiveYears 2023-12-31 07990372 d:BetweenOneFiveYears 2022-12-31 07990372 c:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 07990372 6 2023-01-01 2023-12-31 07990372 d:AcceleratedTaxDepreciationDeferredTax 2023-12-31 07990372 d:AcceleratedTaxDepreciationDeferredTax 2022-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 07990372










CAREMEDS LIMITED










FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2023

 
CAREMEDS LIMITED
REGISTERED NUMBER: 07990372

BALANCE SHEET
AS AT 31 DECEMBER 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 4 
8,707
10,300

Investments
 5 
-
438,573

  
8,707
448,873

Current assets
  

Stocks
  
19,139
25,072

Debtors: amounts falling due within one year
 6 
193,254
157,498

Cash at bank and in hand
 7 
2,099,724
1,413,856

  
2,312,117
1,596,426

Creditors: amounts falling due within one year
 8 
(944,056)
(249,519)

Net current assets
  
 
 
1,368,061
 
 
1,346,907

Total assets less current liabilities
  
1,376,768
1,795,780

Provisions for liabilities
  

Deferred tax
 9 
(2,177)
(2,576)

  
 
 
(2,177)
 
 
(2,576)

Net assets
  
1,374,591
1,793,204


Capital and reserves
  

Called up share capital 
 10 
247
247

Share premium account
 11 
449,537
449,537

Profit and loss account
 11 
924,807
1,343,420

  
1,374,591
1,793,204


Page 1

 
CAREMEDS LIMITED
REGISTERED NUMBER: 07990372
    
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2023

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Mr. G. De Rotalier
Director

Date: 12 February 2024

The notes on pages 3 to 11 form part of these financial statements.

Page 2

 
CAREMEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

1.


General information

The entity is a private company limited by shares, incorporated in England & Wales. The registered office is located at Unit 7, Brickfield Trading Estate, Brickfield Lane, Chandler's Ford, SO53 4DR. The registered company number is 07990372. The principal activity of the company is the provision of software services and supply of medication blister packs to the pharmaceutical industry. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.



 
2.2

Going Concern

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future due to the fact that the company has the continued support of the group. Thus, the directors continue to adopt the going concern basis of accounting in preparing the financial statements. 
 

 
2.3

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Page 3

 
CAREMEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

2.Accounting policies (continued)

 
2.4

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.5

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

 
2.6

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 4

 
CAREMEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

2.Accounting policies (continued)

 
2.7

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date. 

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the Balance Sheet date, except that the recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met. Deferred tax balances are not recognised in respect of permanent differences. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted at the balance sheet date.

 
2.8

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using both the straight-line and reducing balance methods.

Depreciation is provided on the following basis:

Plant and machinery
-
25%
straight line basis
Fixtures and fittings
-
25%
straight line basis
Office equipment
-
33%
straight line basis

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.9

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Page 5

 
CAREMEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

2.Accounting policies (continued)

 
2.10

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

  
2.11

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at a  general meeting.


3.


Employees

The average monthly number of employees, including the directors, during the year was as follows:


        2023
        2022
            No.
            No.







7
7

Page 6

 
CAREMEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

4.


Tangible fixed assets





Plant and machinery
Fixtures and fittings
Office equipment
Total

£
£
£
£



Cost


At 1 January 2023
10,974
11,193
51,762
73,929


Additions
-
1,296
3,740
5,036



At 31 December 2023

10,974
12,489
55,502
78,965



Depreciation


At 1 January 2023
4,651
11,193
47,785
63,629


Charge for the year on owned assets
2,743
324
3,562
6,629



At 31 December 2023

7,394
11,517
51,347
70,258



Net book value



At 31 December 2023
3,580
972
4,155
8,707



At 31 December 2022
6,323
-
3,977
10,300

Page 7

 
CAREMEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

5.


Fixed asset investments





Investments in subsidiary companies

£



Cost


At 1 January 2023
438,573


Disposals
(438,573)



At 31 December 2023
-






Page 8

 
CAREMEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

6.


Debtors

2023
2022
£
£


Trade debtors
152,695
125,902

Amounts owed by group undertakings
10,328
25,460

Other debtors
4,729
4,729

Prepayments and accrued income
25,502
1,407

193,254
157,498



7.


Cash and cash equivalents

2023
2022
£
£

Cash at bank and in hand
2,099,724
1,413,856

2,099,724
1,413,856



8.


Creditors: Amounts falling due within one year

2023
2022
£
£

Trade creditors
29,101
41,379

Amounts owed to group undertakings
668,979
4,794

Corporation tax
135,342
100,926

Other taxation and social security
100,196
93,319

Other creditors
1,238
1,101

Accruals and deferred income
9,200
8,000

944,056
249,519


Page 9

 
CAREMEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

9.


Deferred taxation




2023


£






At beginning of year
(2,576)


Credited to profit or loss
399



At end of year
(2,177)

The provision for deferred taxation is made up as follows:

2023
2022
£
£


Accelerated capital allowances
(2,177)
(2,576)

(2,177)
(2,576)

Page 10

 
CAREMEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

10.


Share capital

2023
2022
£
£
Allotted, called up and fully paid



247 (2022 - 247) Ordinary shares of £1 each
247
247



11.


Reserves

Share premium account

The share premium account reserve consists of amounts paid for shares in excess of their nominal value.

Profit and loss account

The profit and loss account reserve represents retained earnings not distributed.


12.


Commitments under operating leases

At 31 December 2023 the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2023
2022
£
£


Not later than 1 year
5,465
18,500

Later than 1 year and not later than 5 years
2,085
29,500

7,550
48,000


13.


Controlling party

The company is under the control of its parent company, Malta Informatique SAS, a company incorporated in France. During the year Malta Informatique SAS acquired all of the shares in the company previously owned by Equasens SA. At year end the company was a 100% subsidiary of Malta Informatique SAS. 
The smallest group financial statements which include the company is Malta Informatique SAS and accounts can be obtained from their registered office at 5 Allée de Saint-Cloud, 54600 Villers-lès-Nancy, France. 


14.


Auditors' information

The auditors' report on the financial statements for the year ended 31 December 2023 was unqualified.

The audit report was signed on 12 February 2024 by David Fletcher BA BFP FCA (Senior statutory auditor) on behalf of Just Audit Limited.

 
Page 11